Maryland regulators: Is medical marijuana effective for treating opioid addiction? Answer: It’s complicated

As opioid overdose deaths continued to mount in Maryland last year, state lawmakers asked medical marijuana regulators to determine whether cannabis could be effective at treating addiction to heroin, fentanyl and oxycodone. The answer—not really—was submitted to the General Assembly this week by the Maryland Medical Cannabis Commission. “A comprehensive review of existing medical literature shows that there is no […]

Read more

Persistent Opioid Use High in Head, Neck Cancer Patients

FRIDAY, Jan. 11, 2019 — Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery. Jessica D. McDermott, M.D., from the University of Colorado Anschutz School of Medicine in Aurora, and colleagues used data from the Surveillance, Epidemiology […]

Read more

Pediatric Mortality Rate From Opioid Poisoning Rose 1999 to 2016

THURSDAY, Jan. 3, 2019 — From 1999 to 2016, there was close to a threefold increase in the pediatric mortality rate from opioid poisonings in the United States, according to a study published online Dec. 28 in JAMA Network Open. Julie R. Gaither, Ph.D., M.P.H., R.N., from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined national […]

Read more

After naloxone, when can opioid overdose patients be safely discharged?

Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses? According to the St. Paul’s Early Discharge Rule developed in 2000, that’s how long providers should observe patients after naloxone treatment, so long as their vital signs meet specific criteria and […]

Read more

High-strength opioid formulations: The case for the federal minister of health to recall them

One regulatory tool that has yet to be deployed to curb the ongoing opioid epidemic is the power of the federal minister of health to recall high-strength opioid formulations from the market. These opioid formulations can harm patients with chronic pain in multiple ways and the minister could recall them, argues a commentary in CMAJ (Canadian Medical Association Journal). “In […]

Read more

Baby born in withdrawal from kratom tea mom drank during pregnancy

Baby born with withdrawal symptoms from kratom tea that his mother drank during pregnancy A baby boy born in Florida showed signs of the neonatal abstinence syndrome (NAS)  Babies with NAS are born in withdrawal from opioids their mothers used  His mother had been off opioids for two years and mother and son both tested negative for opioids but drank […]

Read more

Impact of opioid epidemic on children varies by state

A new report released by the Drug Enforcement Administration finds most overdose deaths are caused by prescription drugs, including opioids. While opioid abuse continues to plague certain states more than others, each state is unique in how it attempts to stem the crisis and its effect on families. These differences have resulted in significant variation across the country between opioid […]

Read more

FDA Approves Powerful New Opioid, Dsuvia (Sufentanil), Despite Criticisms

FRIDAY, Nov. 2, 2018 — Ruling against the recommendation of one of its chief experts, the U.S. Food and Drug Administration on Friday approved an extremely potent new opioid painkiller, Dsuvia. The drug is a 30-microgram pill that packs the same punch as 5 milligrams of intravenous morphine, according to the Washington Post. The tiny pill comes packaged in a […]

Read more